Pre-pandemic protocols
-
The lungs were — and continue to be — among the organs most affected in COVID-19, both from the wild-type infection and the mRNA vaccines. Hospital admissions and mortality have increased, in part due to ineffective treatment strategies.
We need pandemic-response protocols that help reduce lung inflammation and prevent secondary complications such as hypoxia and thrombosis — for example, through the use of nebulized anti-inflammatory agents. However, it’s crucial that these interventions do not interfere with the host’s immune activity, so that resolution of the infection or post-vaccine syndromes is faster and more effective.
Are there any pulmonary protocols, either for pediatric or adult populations, that use nebulizations with phytotherapeutics or chlorine dioxide? The latter, in particular, has shown potent antioxidant and anti-inflammatory properties in some scientific studies.
I’m also thinking ahead to future pandemics that could similarly affect the lungs — such as H5N1 — and the urgent need to develop safe, immune-compatible respiratory therapies.
Mauricio Arango, MD
Log in to reply.